Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The TRICURE EFS TRiCares Topaz Transfemoral TRICUspid Heart Valve REplacement System Early Feasibility Study

NCT06506942 is registered in ClinicalTrials.gov with TRiCares as lead sponsor.

NCT NCT06506942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06506942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The TRICURE EFS TRiCares Topaz Transfemoral TRICUspid Heart Valve REplacement System Early Feasibility Study
Lead sponsor
TRiCares
Phase
Not applicable
Overall status
Recruiting
Start date
September 11, 2024
Completion date
March 31, 2031
Enrollment
15 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, heart valve diseases, tricuspid valve regurgitation